1. DOP26 COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaign. (21st January 2022) Authors: Lev Zion, R; Focht, G; Lujan, R; Mendelovici, A; Friss, C; Greenfeld, S; Kariv, R; Ben-Tov, A; Matz, E; Nevo, D; Barak-Corren, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP39 Utilization and sustainability of biologics in UC - A nationwide study from the epi-IIRN. (27th May 2021) Authors: Atia, O; Yogev, D; Friss, C; Focht, G; Orlanski-Meyer, E; Magen Rimon, R; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Gorelik, Y; Chowers, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP45 Utilization and sustainability of biologics in CD - A nationwide study from the epi-IIRN. (27th May 2021) Authors: Atia, O; Yogev, D; Chagit, F; Gili, F; Orlanski-Meyer, E; Magen Rimon, R; Natan, L; Shira, G; Kariv, R; Yisca, L W; Gabay, H; Nevo, D; Matz, E; Gorelik, Y; Chowers, Y; Iris, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP46 Sustainability rate of immunomodulators monotherapy in patients with Crohn's Diseases: A population-based analysis from the epi-IIRN cohort. (27th May 2021) Authors: Atia, O; Friss, C; Mendelovici, A; Shteyer, E; Yogev, D; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P244 COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based study. (21st January 2022) Authors: Lev Zion, R; Focht, G; Lujan, R; Mendelovici, A; Friss, C; Greenfeld, S; Kariv, R; Ben-Tov, A; Matz, E; Nevo, D; Barak-Corren, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P616 Sustainability of thiopurines monotherapy in ulcerative colitis: a nationwide analysis from the epi-IIRN cohort. (27th May 2021) Authors: Atia, O; Friss, C; Mendelovici, A; Shteyer, E; Orlanski-Meyer, E; Ledderman, N; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Gabay, H; Nevo, D; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P674 Predictors of response to biologics in Crohn's Diseases: A population-based study from the epi-IIRN. (21st January 2022) Authors: Atia, O; Lujan, R; Greenfeld, S; Kariv, R; Matz, E; Dotan, I; Nevo, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P682 Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRN. (21st January 2022) Authors: Atia, O; Lujan, R; Greenfeld, S; Kariv, R; Matz, E; Dotan, I; Nevo, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗